ABIONYX (EPA:ABNX) | WebDisclosure

Basculer en Français

8596	Companies
140042	Keywords
75988	Articles
74781	Press releases

Home
Companies
ABIONYX

BRIEF

published on 03/21/2025 at 07:35, 12 days 18 hours ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
BRIEF

published on 03/21/2025 at 07:35, 12 days 18 hours ago

CIC Market Solutions recommande l'achat de l'action ABIONYX Pharma

Achat Biopharma Traitements Innovants ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 12 days 18 hours ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
PRESS RELEASE

published on 03/21/2025 at 07:30, 12 days 18 hours ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma bénéficie de l'initiation à l'achat par CIC Market Solutions, un service du Crédit Mutuel Alliance Fédérale, avec une recommandation à l'achat

Crédit Mutuel ABIONYX Pharma CIC Market Solutions Biopharmacie Recommandation Achat
BRIEF

published on 02/28/2025 at 07:35, 1 month 2 days ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
BRIEF

published on 02/28/2025 at 07:35, 1 month 2 days ago

ABIONYX renforce son engagement contre la Déficience LCAT

Autorisation De Mise Sur Le Marché Maladie Rare Déficience LCAT Biomédicament Maladie De Norum
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 month 2 days ago

Informations privilégiées / Autres communiqués
ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA

ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 month 2 days ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF

published on 02/27/2025 at 19:25, 1 month 3 days ago

ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024

2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
BRIEF

published on 02/27/2025 at 19:25, 1 month 3 days ago

ABIONYX Pharma annonce un chiffre d'affaires et une situation de trésorerie stables pour 2024

Résultats Financiers 2024 ABIONYX Pharma Thérapies Innovantes Accès Compassionnel Industrie Des CRO

1 2 ... 6

Accesswire

Published on 04/02/2025 at 23:35, 2 hours ago

Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 5 hours 35 minutes ago

Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 17:25, 8 hours 10 minutes ago

SOBRsafe Announces Reverse Stock Split
Published on 04/02/2025 at 15:00, 10 hours 35 minutes ago

Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 14:00, 11 hours 35 minutes ago

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

View all ACCESSWIRE

EQS Group

Published on 04/02/2025 at 20:20, 5 hours 15 minutes ago

EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 5 hours 34 minutes ago

Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 5 hours 34 minutes ago

Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 5 hours 55 minutes ago

LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 6 hours 22 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 04/03/2025 at 00:37, 58 minutes ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/03/2025 at 00:37, 58 minutes ago

Mise à disposition du rapport sur les paiements faits aux gouvernements prévu à l’article L.225-102-3 du Code de commerce
Published on 04/02/2025 at 18:05, 7 hours 30 minutes ago

Financial statements - 31 december 2024
Published on 04/02/2025 at 17:45, 7 hours 50 minutes ago

Aéroports de Paris SA - Droits de vote au 31 mars 2025
Published on 04/02/2025 at 17:45, 7 hours 50 minutes ago

Aéroports de Paris SA - Voting rights as of 31 March 2025

View all LES ECHOS COMFI WIRE